Document Detail


Association between topiramate and zonisamide use during pregnancy and low birth weight.
MedLine Citation:
PMID:  24463659     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVE: To assess the possible effects of topiramate and zonisamide use during pregnancy on fetal growth.
METHODS: The study population was the singleton liveborns born to women who enrolled in the North American Antiepileptic Drug Pregnancy Registry between 1997 and 2012. Data were collected through telephone interviews at enrollment, 7 months of gestation, and postpartum. The prevalence of small for gestational age at birth among neonates exposed to topiramate and to zonisamide when either was used as monotherapy during pregnancy was compared with that among neonates exposed to lamotrigine monotherapy, a weight-neutral therapy, and the most common antiepileptic drug in the Registry. Relative risks (RRs) and 95% confidence intervals (CIs) were estimated with multivariable log-binomial regression to control for potential confounders.
RESULTS: Data were available for 347 topiramate, 98 zonisamide, and 1,581 lamotrigine-exposed neonates. The mean gestational length was 39 weeks for all comparison groups. Prenatal exposure to topiramate or zonisamide was associated with a mean lower birth weight of 221 and 202 g, respectively, and a mean lesser neonatal length of 1 cm as compared with lamotrigine exposure (p<.01). The prevalence of small for gestational age was 6.8% for lamotrigine, 17.9% for topiramate (RR 2.4, 95% CI 1.8-3.3) and 12.2% for zonisamide (RR 1.6, 0.9-2.8). Similar results were found when a group of 457 unexposed neonates was used as the reference.
CONCLUSIONS: Topiramate and zonisamide have been shown to reduce weight in adults. Our finding of a decrease in mean birth weight and length among neonates exposed in utero raises concern.
LEVEL OF EVIDENCE: : II.
Authors:
Sonia Hernández-Díaz; Robert Mittendorf; Caitlin R Smith; W Allen Hauser; Mark Yerby; Lewis B Holmes;
Related Documents :
7724119 - Histiocytosis x and pregnancy.
18341209 - Role of t-cells in diabetic pregnancy and macrosomia.
3605239 - A hypothesis concerning the general basis of organogenetic congenital anomalies.
15954869 - Period of gestational diabetes mellitus diagnosis and maternal and fetal morbidity.
24724919 - Maternal, placental and fetal exposure to bisphenol a in women with and without preecla...
23777259 - Distribution of poly- and perfluoroalkyl substances in matched samples from pregnant wo...
24163799 - The role of psychological adjustment in the decision-making process for voluntary termi...
12405239 - Abuse during pregnancy and stress because of abuse during pregnancy and birthweight.
17516959 - Severe twin-twin transfusion syndrome: outcome after fetoscopic laser ablation of the p...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  123     ISSN:  1873-233X     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2014 Jan 
Date Detail:
Created Date:  2014-01-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  21-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Milestones to optimal adoption of robotic technology in gynecology.
Next Document:  Validation of the joint commission exclusion criteria for elective early-term delivery.